These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
519 related items for PubMed ID: 23018784
1. Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a three-year study. Popp AW, Guler S, Lamy O, Senn C, Buffat H, Perrelet R, Hans D, Lippuner K. J Bone Miner Res; 2013 Mar; 28(3):449-54. PubMed ID: 23018784 [Abstract] [Full Text] [Related]
3. Cortical bone loss at the tibia in postmenopausal women with osteoporosis is associated with incident non-vertebral fractures: results of a randomized controlled ancillary study of HORIZON. Popp AW, Buffat H, Cavelti A, Windolf M, Perrelet R, Senn C, Lippuner K. Maturitas; 2014 Mar; 77(3):287-93. PubMed ID: 24485216 [Abstract] [Full Text] [Related]
4. Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study. Senn C, Günther B, Popp AW, Perrelet R, Hans D, Lippuner K. Osteoporos Int; 2014 Jul; 25(7):1945-51. PubMed ID: 24760244 [Abstract] [Full Text] [Related]
5. Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate. Sambrook PN, Roux C, Devogelaer JP, Saag K, Lau CS, Reginster JY, Bucci-Rechtweg C, Su G, Reid DM. Bone; 2012 Jan; 50(1):289-95. PubMed ID: 22061864 [Abstract] [Full Text] [Related]
6. Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis. McClung MR, Lippuner K, Brandi ML, Zanchetta JR, Bone HG, Chapurlat R, Hans D, Wang A, Zapalowski C, Libanati C. Osteoporos Int; 2017 Oct; 28(10):2967-2973. PubMed ID: 28748386 [Abstract] [Full Text] [Related]
7. Effects of Teriparatide and Sequential Minodronate on Lumbar Spine Bone Mineral Density and Microarchitecture in Osteoporosis. Miyaoka D, Imanishi Y, Ohara M, Hayashi N, Nagata Y, Yamada S, Mori K, Emoto M, Inaba M. Calcif Tissue Int; 2017 Oct; 101(4):396-403. PubMed ID: 28589205 [Abstract] [Full Text] [Related]
8. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate. McClung M, Recker R, Miller P, Fiske D, Minkoff J, Kriegman A, Zhou W, Adera M, Davis J. Bone; 2007 Jul; 41(1):122-8. PubMed ID: 17468062 [Abstract] [Full Text] [Related]
9. Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis. Chen P, Miller PD, Recker R, Resch H, Rana A, Pavo I, Sipos AA. J Bone Miner Res; 2007 Aug; 22(8):1173-80. PubMed ID: 17451369 [Abstract] [Full Text] [Related]
10. "Trabecular Bone Score" (TBS): an indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism. Romagnoli E, Cipriani C, Nofroni I, Castro C, Angelozzi M, Scarpiello A, Pepe J, Diacinti D, Piemonte S, Carnevale V, Minisola S. Bone; 2013 Mar; 53(1):154-9. PubMed ID: 23228370 [Abstract] [Full Text] [Related]
11. Spine trabecular bone score subsequent to bone mineral density improves fracture discrimination in women. Krueger D, Fidler E, Libber J, Aubry-Rozier B, Hans D, Binkley N. J Clin Densitom; 2014 Mar; 17(1):60-5. PubMed ID: 23769698 [Abstract] [Full Text] [Related]
12. TBS and BMD at the end of AI-therapy: A prospective study of the B-ABLE cohort. María RS, Marta PM, Sonia S, Natalia GG, Tamara M, Ignasi T, Maria MG, Jaime RM, Adolfo DP, Joan A, Xavier N. Bone; 2016 Nov; 92():1-8. PubMed ID: 27519968 [Abstract] [Full Text] [Related]
17. Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism. Eller-Vainicher C, Morelli V, Ulivieri FM, Palmieri S, Zhukouskaya VV, Cairoli E, Pino R, Naccarato A, Scillitani A, Beck-Peccoz P, Chiodini I. J Bone Miner Res; 2012 Oct; 27(10):2223-30. PubMed ID: 22549969 [Abstract] [Full Text] [Related]
18. Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-month analysis of the E-ZO-FAST trial. Llombart A, Frassoldati A, Paija O, Sleeboom HP, Jerusalem G, Mebis J, Deleu I, Miller J, Schenk N, Neven P. Clin Breast Cancer; 2012 Feb; 12(1):40-8. PubMed ID: 22014381 [Abstract] [Full Text] [Related]
19. The Trabecular Bone Score Predicts Spine Fragility Fractures in Postmenopausal Caucasian Women Without Osteoporosis Independently of Bone Mineral Density. Ripamonti C, Lisi L, Buffa A, Gnudi S, Caudarella R. Med Arch; 2018 Feb; 72(1):46-50. PubMed ID: 29416218 [Abstract] [Full Text] [Related]
20. Predicting subsequent bone density response to intermittent cyclical therapy with etidronate from initial density response in patients with osteoporosis. Crilly RG, Sebaldt RJ, Hodsman AB, Adachi JD, Brown JP, Goldsmith CH, Hanley DA, Olszynski WO, Ste-Marie LG, Stephenson GF. Osteoporos Int; 2000 Feb; 11(7):607-14. PubMed ID: 11069195 [Abstract] [Full Text] [Related] Page: [Next] [New Search]